Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Rheumatoid Arthritis

  Free Subscription


20.02.2023

11 Ann Rheum Dis
2 Clin Rheumatol
1 Curr Opin Rheumatol
1 J Arthroplasty
1 J Rheumatol
3 PLoS One
3 Scand J Rheumatol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Rheum Dis

  1. FRISELL T, Bower H, Morin M, Baecklund E, et al
    Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme.
    Ann Rheum Dis. 2023 Feb 14:ard-2022-223762. doi: 10.1136/ard-2022-223762.
    PubMed         Abstract available


  2. Correction: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
    Ann Rheum Dis. 2023;82:e76.
    PubMed        


  3. News from EULAR.
    Ann Rheum Dis. 2023;82:448.
    PubMed        

  4. LOPES AP, Hillen MR, Hinrichs AC, Blokland SL, et al
    Deciphering the role of cDC2s in Sjogren's syndrome: transcriptomic profile links altered antigen processes with IFN signature and autoimmunity.
    Ann Rheum Dis. 2023;82:374-383.
    PubMed         Abstract available

  5. WANG B, Chen S, Xuan J, Li Y, et al
    Correspondence on 'Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial'.
    Ann Rheum Dis. 2023;82:e67.
    PubMed        

  6. FELTEN R, Gottenberg JE
    Response to: 'Correspondence on 'Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial'' by Wang et al.
    Ann Rheum Dis. 2023;82:e68.
    PubMed        

  7. AYDIN SZ, Hepworth E, Tugwell P
    Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'.
    Ann Rheum Dis. 2023;82:e69.
    PubMed        

  8. FREITES NUNEZ DD, Leon L, Mucientes A, Rodriguez-Rodriguez L, et al
    Response to: 'Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'' by Aydin et al.
    Ann Rheum Dis. 2023;82:e70.
    PubMed        

  9. MOUTSOPOULOS HM
    Correspondence on 'Jan Gosta Waldenstrom and rheumatology'.
    Ann Rheum Dis. 2023;82:e59.
    PubMed        

  10. NOVELLA-NAVARRO M, Plasencia-Rodriguez C, Tornero C, Navarro-Compan V, et al
    Correspondence on: 'EULAR definition of difficult-to-treat rheumatoid arthritis'.
    Ann Rheum Dis. 2023;82:e55.
    PubMed        

  11. ROODENRIJS NMT, Welsing PMJ, van der Goes MC, Jacobs JW, et al
    Response to: 'Correspondence on 'EULAR definition of difficult-to-treat rheumatoid arthritis'' by Novella-Navarro et al.
    Ann Rheum Dis. 2023;82:e56.
    PubMed        


    Clin Rheumatol

  12. ABUELAZM M, Ghanem A, Mahmoud A, Brakat AM, et al
    The efficacy and safety of olokizumab for rheumatoid arthritis: a systematic review, pairwise, and network meta-analysis.
    Clin Rheumatol. 2023 Feb 16. doi: 10.1007/s10067-023-06519.
    PubMed         Abstract available

  13. KHABBAZI A, Gadakchi L, Moslemi M, Khalaji A, et al
    Prevalence and predictors of long-term remission in rheumatoid arthritis in real-world practice: a longitudinal study.
    Clin Rheumatol. 2023 Feb 17. doi: 10.1007/s10067-023-06548.
    PubMed         Abstract available


    Curr Opin Rheumatol

  14. MINHAS D, Murphy A, Clauw DJ
    Fibromyalgia and centralized pain in the rheumatoid arthritis patient.
    Curr Opin Rheumatol. 2023 Feb 13. doi: 10.1097/BOR.0000000000000929.
    PubMed         Abstract available


    J Arthroplasty

  15. JIANG W, Jiang X, Xu H, Liu H, et al
    The impact of perioperative use of non-biologic disease-modifying anti-rheumatic drugs on perioperative blood loss and complications in patients who have rheumatoid arthritis undergoing total knee arthroplasty.
    J Arthroplasty. 2023 Feb 8:S0883-5403(23)00079.
    PubMed         Abstract available


    J Rheumatol

  16. MAICA GL, Iannaccone C, Feathers V, Frits ML, et al
    Understanding Differences in Patient Descriptions of Rheumatoid Arthritis Flares Using OMERACT Core Domains.
    J Rheumatol. 2023 Feb 1:jrheum.211409. doi: 10.3899/jrheum.211409.
    PubMed         Abstract available


    PLoS One

  17. HA SJ, Park SJ, Lee B, Moon H, et al
    Clinical outcomes of patients with rheumatoid arthritis who underwent percutaneous coronary intervention: A Korean nationwide cohort study.
    PLoS One. 2023;18:e0281067.
    PubMed         Abstract available

  18. IZUMI K, Suzuki K, Hashimoto M, Endoh T, et al
    Detecting hand joint ankylosis and subluxation in radiographic images using deep learning: A step in the development of an automatic radiographic scoring system for joint destruction.
    PLoS One. 2023;18:e0281088.
    PubMed         Abstract available

  19. NGUYEN THP, Fagerland MW, Hollan I, Whist JE, et al
    High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis.
    PLoS One. 2023;18:e0281155.
    PubMed         Abstract available


    Scand J Rheumatol

  20. RASMUSSEN SL, Strandbygaard LL, Fuursted K, Kragholm KH, et al
    Antibody response in patients with autoimmune inflammatory rheumatic disease after pneumococcal polysaccharide prime vaccination or revaccination.
    Scand J Rheumatol. 2023;52:174-180.
    PubMed         Abstract available

  21. OLSSON P, Ekblad F, Hassler A, Bengtsson M, et al
    Complications after minor salivary gland biopsy: a retrospective study of 630 patients from two Swedish centres.
    Scand J Rheumatol. 2023;52:208-216.
    PubMed         Abstract available

  22. YU X, Zhu F, Yu X, Wang J, et al
    Serum CCL28 as a biomarker for diagnosis and evaluation of Sjogren's syndrome.
    Scand J Rheumatol. 2023;52:200-207.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: